Faculty, Staff and Student Publications
Language
English
Publication Date
1-1-2026
Journal
Haemophilia
DOI
10.1111/hae.70275
PMID
41891800
PMCID
PMC13175425
PubMedCentral® Posted Date
3-27-2026
PubMedCentral® Full Text Version
Post-print
Abstract
Introduction: The 2021 ASH/ISTH/NHF/WFH VWD diagnosis guidelines recommend Type 1 VWD diagnoses for patients with (a) VWF < 0.30 IU/mL or (b) 'Low VWF' 0.30-0.50 IU/mL with the presence of abnormal bleeding. This recommendation recategorizes 'Low VWF' patients with abnormal bleeding into Type 1 VWD.
Aim: To assess the impact of the 2021 VWD guidelines on the diagnosis and management of 'Low VWF' patients.
Methods: A single centre retrospective study was conducted to review all patients presenting for VWD evaluation between January 2000 to September 2024, analyzing for clinical features, ISTH-BAT scores, VWF/FVIII levels, and management of bleeding. 149 patients, totalling 305 clinical encounters, were included in the study.
Results: Seventy five percent of patient encounters had a change in diagnosis from 'Low VWF' to Type 1 VWD after applying the 2021 VWD diagnosis guidelines. The use of VWF therapy (statistically significant, p = 0.04) and antifibrinolytics (not statistically significant, p = 0.52) increased in the post-guidelines period compared to pre-guidelines period. More than half saw increasing VWF levels with age, emphasizing the need to periodically re-evaluate/re-test patients with 'Low VWF'.
Conclusion: Applying the 2021 VWD guidelines leads to improved diagnosis and management of symptomatic patients with 'Low VWF' as they are now classified as Type 1 VWD and receive optimal care with increased use of haemostatic therapy.
Keywords
Humans, Retrospective Studies, Male, Female, von Willebrand Diseases, Middle Aged, Adult, Practice Guidelines as Topic, von Willebrand Factor, Adolescent, Child, Young Adult, Aged, Child, Preschool, Disease Management, low VWF, type 1 VWD, VWD guidelines
Published Open-Access
yes
Recommended Citation
Dong, Michael; Larson, Joanna; Saroukhani, Sepideh; et al., "Assessing the Impact of the 2021 VWD Guidelines on the Diagnosis/Management of Low VWF Patients" (2026). Faculty, Staff and Student Publications. 4264.
https://digitalcommons.library.tmc.edu/uthmed_docs/4264